PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33542212-1	2021	Polyglutamine (polyQ) diseases comprise Huntington"s disease and several subtypes of spinocerebellar ataxia, including spinocerebellar ataxia type 3 (SCA3).	polyglutamine	0-13	ataxin 3	Homo sapiens	119-148	
33542212-1	2021	Polyglutamine (polyQ) diseases comprise Huntington"s disease and several subtypes of spinocerebellar ataxia, including spinocerebellar ataxia type 3 (SCA3).	polyglutamine	0-13	ataxin 3	Homo sapiens	150-154	
33542212-1	2021	Polyglutamine (polyQ) diseases comprise Huntington"s disease and several subtypes of spinocerebellar ataxia, including spinocerebellar ataxia type 3 (SCA3).	polyglutamine	15-20	ataxin 3	Homo sapiens	119-148	
33542212-1	2021	Polyglutamine (polyQ) diseases comprise Huntington"s disease and several subtypes of spinocerebellar ataxia, including spinocerebellar ataxia type 3 (SCA3).	polyglutamine	15-20	ataxin 3	Homo sapiens	150-154	
33542212-10	2021	Our data suggest that Exoc7/exo70 exerts its ATXN3-polyQ-modifying effect through regulating the E3 ligase function of Prpf19/prp19.	polyglutamine	51-56	ataxin 3	Homo sapiens	45-50